Liver transplant and chronic hepatitis B virus infection.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Experimental and Clinical Transplantation

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 21453226
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post–liver transplantation hepatitis B prophylaxis

  2008cited by this paper
• Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

  2008cited by this paper
• HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.

  2007cited by this paper
• Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients.

  2007cited by this paper
• Telbivudine versus lamivudine in patients with chronic hepatitis B.

  2007cited by this paper
• Adherence to Lamivudine after an early withdrawal of hepatitis B immune globulin plays an important role in the long-term prevention of hepatitis B virus recurrence.

  2007cited by this paper
• Adefovir dipivoxil for wait‐listed and post–liver transplantation patients with lamivudine‐resistant hepatitis B: Final long‐term results

  2007cited by this paper
• Virologic response and resistance to adefovir in patients with chronic hepatitis B.

  2006cited by this paper
• Prophylactic strategies for hepatitis B patients undergoing liver transplant: A cost‐effectiveness analysis

  2006cited by this paper
• Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.

  2005cited by this paper
• Low-Dose Hepatitis B Immune Globulin and Higher-Dose Lamivudine Combination to Prevent Hepatitis B Virus Recurrence after Liver Transplantation

  2004cited by this paper
• A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation.

  2003cited by this paper
• Prevention of recurrent hepatitis B post–liver transplantation

  2002cited by this paper
• A concise update on the status of liver transplantation for hepatitis B virus: The challenges in 2002

  2002cited by this paper
• Reduced doses of hepatitis B immunoglobulin protect against hepatitis B virus infection recurrence after liver transplantation.

  2001cited by this paper
• Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

  1998cited by this paper
• Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.

  1997cited by this paper
• Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro

  1995cited by this paper
• Liver transplantation in European patients with the hepatitis B surface antigen.

  1993cited by this paper
• The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer.

  1988cited by this paper
• Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts.

  1987cited by this paper

• YMDD Motif Mutation Profile Among Patients Receiving Liver Transplant Due to Hepatitis B Virus Infection With Long Term Lamivudine/Immunoglobulin Therapy

  2015cites this paper
• Management of Chronic Hepatitis in Special Hosts and Special Situations: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases

  2015influential citation
• Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms

  2013cites this paper
• Management of Patients with Chronic Hepatitis B Before and After Liver Transplantation: An Update

  2012cites this paper